The focus here is on personalised medicine, which enables individual therapies through the analysis of molecular causes. This is in contrast to traditional ...

Medical Strategy is a portfolio manager specializing in investments in companies in the healthcare sector.

Medical Strategy has been licensed for financial portfolio management by the German Federal Financial Supervisory Authority (BaFin ID: 112465) since 1998. In ...

Im Mittelpunkt steht dabei die personalisierte Medizin, die durch Analyse der molekularen Ursachen individuelle und zielgerichtete Therapien ermöglicht. Sie ... Team · Investmentprozess · Einblicke · Disclaimer

Within the scope of our core competence, we focuse exclusively on the management and advisory of equity portfolios in the healthcare/biotech sector.

Medical Strategy GmbH, sector: Financials, industry: Financial Services, sub-industry: Asset Management, incorporated: 08/24/2007, address: Graefeling Germany.

Life Sciences Business Intelligence Axtarish Portal for European countries.

Medical Strategies International is a strategic business firm focused on the medical device and supply industry. MSI's Managing Partners are each highly trained ...

Medical Strategy GmbH · Upcoming Axtarishcasts · Past Axtarishcasts · Latest News · Upcoming Events · Latest Reports · Latest Research.

They are responsible for educating internal and external stakeholders on scientific topics, care pathway and patient outcomes.